Surgery – Truss – Pad
Patent
1990-01-12
1991-06-04
Cohen, Lee S.
Surgery
Truss
Pad
128734, 128696, A61B 508
Patent
active
050205412
ABSTRACT:
A method and apparatus for use with medical electrode systems that sense the integrity of lead connections and patient transthoracic impedance is provided. In an ECG electrode application, a carrier circuit (12) produces two carrier signals (S.sub.C1 and S.sub.C2) that are out of phase with each other. The S.sub.C1 signal is applied to an RA lead through a terminating impedance (Z1). The S.sub.C2 signal is applied to LA, LL and V leads through terminating impedances (Z2, Z3, and Z4). Each of the S.sub.C1 and S.sub.C2 carrier signals comprises a lead impedance frequency component (S.sub.LI) and an impedance respiration frequency component (S.sub.IR). First stage amplifiers (A1, A2, and A3) located in an ECG preamplifier (13) amplify the difference between a lead voltage on the RA lead (V.sub.RA) and lead voltages on the LA, LL, and V leads (V.sub.LA, V.sub.LL and V.sub.V). High pass filters (F1, F2 and F3) remove patient ECG signals from the outputs of A1, A2 and A3 to produce first stage output voltages (V.sub.1, V.sub.2 and V.sub.5). The V.sub.1, V.sub.2 and V.sub.5 voltages are demodulated by a demodulator circuit (18). Lead impedance demodulators (DM1, DM2 and DM3) are clocked by a lead impedance control signal (S.sub.A) that has the same frequency as the S.sub.LI component so that the outputs of DM1, DM2 and DM3 are lead impedance-related voltages (V.sub.L1, V.sub.L2 and V.sub.L5). V.sub.2 is also demodulated by an impedance respiration demodulator (DM4). DM4 is clocked by an impedance respiration control signal (S.sub.B) that has the same frequency as the S.sub.IR component so that the output of DM4 is a transthoracic impedance-related voltage V.sub.T. V.sub.T is amplified by an operational amplifier (OA10) to produce an impedance respiration-related voltage (V.sub.R). The ECG preamplifier (13) and the demodulator circuit (18) include fast DC restoration circuits (66, 68, 70 and 71) that use switched capacitor integrators (76) to restore ECG outputs (V.sub.E1, V.sub.E2, and V.sub.E5) and the V.sub.R voltage to nominal values when a DC offset has occurred.
REFERENCES:
patent: 3608542 (1971-09-01), Pacela
patent: 4141351 (1979-02-01), James et al.
patent: 4416288 (1983-11-01), Freeman
patent: 4459993 (1984-07-01), Foreman
patent: 4478223 (1984-10-01), Allor
patent: 4527567 (1985-07-01), Fischler et al.
patent: 4565201 (1986-01-01), Lass
patent: 4577639 (1986-03-01), Simon et al.
patent: 4580575 (1986-04-01), Birnbaum et al.
patent: 4610254 (1986-09-01), Morgan et al.
patent: 4619265 (1986-10-01), Morgan et al.
patent: 4630204 (1986-12-01), Mortara
patent: 4679144 (1987-07-01), Cox et al.
patent: 4785812 (1988-11-01), Pihl et al.
patent: 4840182 (1986-06-01), Carlson
patent: 4919145 (1990-04-01), Marriott
Cohen Lee S.
Physio-Control Corporation
Zele John D.
LandOfFree
Apparatus for sensing lead and transthoracic impedances does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus for sensing lead and transthoracic impedances, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus for sensing lead and transthoracic impedances will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1020111